ISSN: 0019-509X

Journal Home

Journal Guideline

Indian Journal of Cancer Q3 Unclaimed

Wolters Kluwer Medknow Publications India

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Indian Journal of Cancer is a journal indexed in SJR in Oncology with an H index of 47. It has an SJR impact factor of 0,31 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,31.

Indian Journal of Cancer focuses its scope in these topics and keywords: cancer, breast, carcinoma, cell, inhibitors, kinase, lung, nonsmall, patients, profiles, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Oncology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,31

SJR Impact factor

47

H Index

139

Total Docs (Last Year)

335

Total Docs (3 years)

3641

Total Refs

290

Total Cites (3 years)

280

Citable Docs (3 years)

0.88

Cites/Doc (2 years)

26.19

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

American Journal of Clinical Oncology Q3
American Journal of Clinical Oncology: Cancer Clinical Trials Q3
Oncology Letters Q3
World Journal of Oncology Q3
Hereditary Cancer in Clinical Practice Q3

Compare this journals

Aims and Scope

Best articles by citations

Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma

Streptococcus bovis bacteremia and colorectal carcinoma

Pathology of advanced buccal mucosa cancer involving masticator space (T4b)

Time trend in frequency of occurrence of major immunophenotypes in paediatric acute lymphoblastic leukemia cases as experienced by Cancer Institute, Chennai, south India during the period 1989-2009

PET/CT in pediatric oncology

Time trend: The mighty teacher

Should every cholecystectomy specimen be sent for histopathology to identify incidental gall bladder cancer?

Peer-review and post-publication discourse: The challenges

Gutka syndrome and oral submucous fibrosis: Few observations

Solitary plasmacytoma of the rib: A rare cytological detection

Langhans and Langerhans are different people and have different eponymous cells

Thinking about the individual in the midst of cancer

SHOW MORE ARTICLES

Mucoepidermoid carcinoma of the sublingual gland associated with Sjogren's syndrome

Mantle cell lymphoma, blastoid variant presenting as acute leukemia - A rare case report

Dual use of tobacco among Bangladeshi men

Whole saliva physico-biochemical changes and quality of life in head and neck cancer patients following conventional radiation therapy: A prospective longitudinal study

Breast cancer and lifestyle

Detailed study of survival of patients with renal cell carcinoma in India

Grossing and reporting of testicular tumor specimens : An evidence-based approach

"Metformin: ""Old warrior for a new battle"

Acute promyelocytic leukemia: An experience from a tertiary care centre in north India

Exploring the role of FDG-PET in the assessment of bone marrow involvement in lymphoma patients as interpreted by qualitative and semiquantitative disease metabolic activity parameter

Synchronous carcinoma breast with chronic myelogenous leukemia: A rare presentation

A retrospective study of 18 cases of adenoid cystic cancer at a tertiary care centre in Delhi